tiprankstipranks
Trending News
More News >
AdvanSix Inc. (ASIX)
NYSE:ASIX
Advertisement

AdvanSix (ASIX) AI Stock Analysis

Compare
333 Followers

Top Page

ASIX

AdvanSix

(NYSE:ASIX)

Rating:73Outperform
Price Target:
$23.50
▲(10.90% Upside)
AdvanSix's overall stock score reflects a strong valuation and positive technical indicators, which are the most significant factors. The company's balanced financial performance and strategic board expansion further support its potential. However, challenges highlighted in the earnings call, such as decreased sales and higher costs, temper the overall outlook.

AdvanSix (ASIX) vs. SPDR S&P 500 ETF (SPY)

AdvanSix Business Overview & Revenue Model

Company DescriptionAdvanSix Inc. manufactures and sells polymer resins in the United States and internationally. It offers Nylon 6, a polymer resin, which is a synthetic material used to produce fibers, filaments, engineered plastics and films. The company also provides caprolactam to manufacture polymer resins; ammonium sulfate fertilizers to distributors, farm cooperatives, and retailers; and acetone that are used in the production of adhesives, paints, coatings, solvents, herbicides, and engineered plastic resins, as well as other intermediate chemicals, including phenol, alpha-methyl styrene, cyclohexanone, methyl ethyl ketoxime, acetaldehyde oxime, 2-pentanone oxime, cyclohexanol, sulfuric acid, ammonia, and carbon dioxide. It offers its products under the Aegis, Capra, Sulf-N, Nadone, Naxol, and EZ-Blox brands. The company sells its products directly, as well as through distributors. AdvanSix Inc. was incorporated in 2016 and is headquartered in Parsippany, New Jersey.
How the Company Makes MoneyAdvanSix generates revenue primarily through the sale of its nylon and chemical products. Key revenue streams include the production and sale of caprolactam, which is a precursor for nylon production, and nylon resins utilized in a variety of applications. Additionally, the company earns revenue from ammonium sulfate, a byproduct of its manufacturing processes, which is sold as a fertilizer. AdvanSix benefits from strategic partnerships with various customers across different industries, enabling it to secure long-term contracts that provide stable income. Fluctuations in raw material prices and global demand for nylon and related products also significantly impact its earnings.

AdvanSix Earnings Call Summary

Earnings Call Date:Aug 01, 2025
(Q2-2025)
|
% Change Since: |
Next Earnings Date:Oct 31, 2025
Earnings Call Sentiment Neutral
AdvanSix reported strong sequential improvement in earnings and made notable achievements in corporate social responsibility and carbon capture tax credits. However, the company faced challenges with decreased sales, higher raw material costs, and lower free cash flow, contributing to a balanced performance overall.
Q2-2025 Updates
Positive Updates
Resilient Earnings and Strong Sequential Improvement
AdvanSix delivered resilient earnings with strong sequential improvement in the second quarter, driven by strong volume and pricing performance from the plant nutrients business.
Corporate Social Responsibility Achievement
AdvanSix received a 2025 gold rating for corporate social responsibility from Ecovadis, placing them in the top 3% of all companies assessed.
Progress on 45Q Carbon Capture Tax Credits
AdvanSix claimed an additional $8 million in 45Q carbon capture tax credits in the second quarter, bringing the total to nearly $20 million for the 2018 through 2020 periods.
Favorable Ammonium Sulfate Market Conditions
The plant nutrients business saw a 7% increase in domestic granular sales volume, supported by favorable North American ammonium sulfate supply and demand conditions.
Negative Updates
Decreased Sales and Softer Demand
Sales of $410 million in the quarter decreased approximately 10% versus the prior year, primarily driven by softer demand in key nylon end markets, including engineered plastics applications serving the auto sector.
Impact of Higher Raw Material Costs
Earnings and cash flow were impacted by higher raw material costs, mainly natural gas and sulfur, affecting margins despite strong volume and pricing performance from the plant nutrients business.
Lower Free Cash Flow
Cash flow from operations of $21 million decreased $29 million versus the prior year, leading to a negative $7 million of free cash flow in the quarter.
Challenges in Nylon and Caprolactam Markets
There was a reduction in caprolactam and nylon volume, impacting sales volume unfavorably by about $5 million year-over-year.
Company Guidance
In the AdvanSix Second Quarter 2025 Earnings Conference Call, the company provided guidance indicating robust performance in certain areas despite challenging market conditions. Sales for the quarter were reported at $410 million, reflecting a 10% decrease from the previous year, primarily due to an 8% drop in sales volume, notably in the nylon segment. However, the plant nutrients division showed strength, with increased pricing and a 7% rise in domestic granular sales volume within the fertilizer year. The company adjusted its CapEx forecast to a range of $135 million to $145 million, reflecting strategic prioritization and timing adjustments. AdvanSix reported an adjusted EBITDA of $56 million, with a margin of 13.6%, and adjusted earnings per share of $1.24. Additionally, the company highlighted the substantial value from 45Q carbon capture tax credits, with $8 million claimed in the second quarter, contributing to a near $20 million total for the 2018-2020 periods, reinforcing its commitment to sustainable growth and profitability.

AdvanSix Financial Statement Overview

Summary
AdvanSix shows a balanced financial profile with strong cash flow generation and effective equity management. Despite revenue growth challenges, cost control supports profitability. Debt levels are a concern but are offset by a stable equity base.
Income Statement
65
Positive
AdvanSix shows modest profitability with a TTM gross profit margin of 4.53% and a net profit margin of 5.10%. Revenue has declined since 2022, indicating some challenges in maintaining growth. The EBIT and EBITDA margins are relatively low but stable, reflecting efficient cost management amidst revenue pressures.
Balance Sheet
72
Positive
The balance sheet reflects a solid equity position with a debt-to-equity ratio of 0.46 and an equity ratio of 50.03% as of TTM. Return on equity has improved to 9.39%, indicating effective utilization of shareholder funds. However, the increasing debt levels could pose a risk if not carefully managed.
Cash Flow
70
Positive
AdvanSix has demonstrated strong operating cash flow, with a TTM operating cash flow to net income ratio of 1.99. Free cash flow has fluctuated but shows a positive trend. The free cash flow to net income ratio is 0.71, indicating a healthy conversion of income to cash, though capital expenditures remain substantial.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue1.52B1.52B1.53B1.95B1.68B1.16B
Gross Profit180.79M152.94M165.09M314.48M274.12M133.75M
EBITDA79.52M133.06M149.72M297.93M255.48M123.66M
Net Income77.33M44.15M54.62M171.89M139.79M46.08M
Balance Sheet
Total Assets1.65B1.59B1.50B1.50B1.31B1.26B
Cash, Cash Equivalents and Short-Term Investments18.45M19.56M29.77M30.98M15.10M10.61M
Total Debt377.75M348.89M266.01M230.04M271.71M389.88M
Total Liabilities822.67M820.27M756.78M757.15M710.81M819.28M
Stockholders Equity823.73M774.65M739.24M738.18M601.19M444.12M
Cash Flow
Free Cash Flow55.07M1.69M10.17M184.15M162.04M28.93M
Operating Cash Flow153.97M135.41M117.55M273.60M218.85M111.85M
Investing Cash Flow-138.50M-142.90M-110.90M-189.27M-67.56M-84.10M
Financing Cash Flow-9.13M-2.71M-7.87M-68.44M-146.79M-24.19M

AdvanSix Technical Analysis

Technical Analysis Sentiment
Positive
Last Price21.19
Price Trends
50DMA
21.29
Negative
100DMA
21.99
Negative
200DMA
24.70
Negative
Market Momentum
MACD
0.12
Negative
RSI
55.53
Neutral
STOCH
62.46
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ASIX, the sentiment is Positive. The current price of 21.19 is above the 20-day moving average (MA) of 20.19, below the 50-day MA of 21.29, and below the 200-day MA of 24.70, indicating a neutral trend. The MACD of 0.12 indicates Negative momentum. The RSI at 55.53 is Neutral, neither overbought nor oversold. The STOCH value of 62.46 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for ASIX.

AdvanSix Risk Analysis

AdvanSix disclosed 30 risk factors in its most recent earnings report. AdvanSix reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

AdvanSix Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
73
Outperform
$564.80M7.419.85%3.02%1.31%796.76%
64
Neutral
$456.23M4.579.65%1.96%4.04%283.22%
62
Neutral
$10.28B6.210.76%2.84%3.10%-36.03%
57
Neutral
$589.88M-6.51%2.60%-1506.69%
50
Neutral
$379.22M-81.36%-4.90%-458.80%
45
Neutral
$662.63M-14.11%9.49%0.20%-292.54%
42
Neutral
$78.68M-25.50%-15.84%-605.38%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
ASIX
AdvanSix
21.19
-5.64
-21.02%
LXU
Lsb Industries
8.37
1.18
16.41%
VHI
Valhi
16.30
-11.95
-42.30%
TROX
TRONOX
4.48
-6.90
-60.63%
RYAM
Rayonier Advanced Materials
5.93
-1.43
-19.43%
ORGN
Origin Materials
0.52
-0.86
-62.32%

AdvanSix Corporate Events

Executive/Board Changes
AdvanSix Expands Board with Two New Directors
Positive
Sep 2, 2025

On September 2, 2025, AdvanSix appointed Dana O’Brien and Daryl Roberts as independent directors to its Board, expanding it to nine members, with eight being independent. O’Brien, with a background in legal leadership across various industries, will serve on the Nominating and Governance Committee and the Compensation and Leadership Development Committee, while Roberts, with extensive experience in global manufacturing, will join the Health, Safety and Environmental Committee and the Compensation and Leadership Development Committee. These appointments are expected to enhance AdvanSix’s corporate governance and strategic oversight, supporting the company’s growth and shareholder value.

DividendsFinancial Disclosures
AdvanSix Announces Dividend Amid Sales Decline
Neutral
Aug 1, 2025

On August 1, 2025, AdvanSix announced a cash dividend of $0.16 per share to be paid on August 26, 2025, to stockholders of record as of August 12, 2025. The company reported its second quarter 2025 financial results, showing a 10% decrease in sales to $410 million compared to the previous year, with a decline in earnings per share and cash flow from operations. Despite challenges such as higher raw material prices and softer demand in key markets, AdvanSix demonstrated resilience with strong performance in its Plant Nutrients business and claimed $8 million in carbon capture tax credits, supporting its long-term sustainable performance.

Executive/Board Changes
AdvanSix Appoints Interim CFO After Sudden Departure
Neutral
Jul 9, 2025

On July 9, 2025, AdvanSix Inc. announced the termination of Siddharth Manjeshwar as Senior Vice President and Chief Financial Officer, effective immediately. Christopher Gramm has been appointed as Interim CFO while the company searches for a permanent replacement. Mr. Gramm, who has been with the company since its spin-off in 2016, previously held roles in financial planning and analysis and has extensive experience from his tenure at Honeywell. The company clarified that Mr. Manjeshwar’s departure was not due to any disagreements with the company’s management or board.

Executive/Board ChangesShareholder MeetingsBusiness Operations and Strategy
AdvanSix Stockholders Approve Key Proposals at Annual Meeting
Neutral
Jun 20, 2025

At the Annual Meeting of Stockholders held on June 18, 2025, AdvanSix Inc. received approval from its stockholders for several key proposals, including the election of directors, ratification of independent accountants, and approval of executive compensation. Notably, the stockholders approved an amendment to the 2016 Stock Incentive Plan, increasing the share reserve by 1,400,000 shares and extending its term to 2035, as well as an amendment to the Certificate of Incorporation to limit officer liability. These decisions are expected to impact the company’s governance and operational strategies moving forward.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 06, 2025